Yttrium-90 (Y-90) resin microspheres

DEVICE2 trials

Sponsors

M.D. Anderson Cancer Center, GrandPharma (China) Co., Ltd.

Conditions

Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma Non-ResectableMetastases

Phase 1

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

RecruitingNCT05195710

M.D. Anderson Cancer CenterMetastases

Start: 2022-11-16End: 2028-03-31Target: 50Updated: 2026-05-26

Unknown Phase

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

Enrolling by invitationNCT06712017

GrandPharma (China) Co., Ltd.Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable

Start: 2024-08-22End: 2025-06-30Target: 100Updated: 2024-12-05